3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
47
Carcinoma, Hepatocellular
9
Triple Negative Breast Neoplasms
7
Stomach Neoplasms
6
Inflammatory Breast Neoplasms
6
Lymphoma, Large B-Cell, Diffuse
4
Urinary Bladder Neoplasms
3
Non-Muscle Invasive Bladder Neoplasms
3
Esophageal Neoplasms
3
Recurrence
2
Lymphoma
2
Breast Neoplasms, Male
2
Breast Diseases
2
Upper Tract Urothelial Carcinoma
1
Thymoma
1
Small Cell Lung Cancer Extensive Stage
1
Sarcoma
1
Prostatic Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Complications
1
Pancreatic Neoplasms
1
Oesophagogastric Cancer
1
Neoplastic Cells, Circulating
1
Neoplasms, Unknown Primary
1
Neoplasms
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell
1
Lung Neoplasms
1
Liver Neoplasms
1
Leiomyosarcoma
1
Interventions
Amplified Fragment Length Polymorphism Analysis
2
entrectinib
1
Vinorelbine
1
Trastuzumab
1
Radiomics
1
Pharmacogenomic Testing
1
Neoadjuvant Therapy
1
Molecular Diagnostic Techniques
1
Letrozole
1
Goserelin
1
Gene Expression Profiling
1
Epirubicin
1
Docetaxel
1
Cyclophosphamide
1
Capecitabine
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Carcinoma, Lobular
×
Epirubicin
×
Clear all
NCT01641406
2012-07-16
NACprotocol
Auxilio Mutuo Cancer Center
Phase 2
Unknown
60 enrolled